{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:35:27Z","timestamp":1791531327922,"version":"4.3.4"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:p>\n                    Metabolic acidosis is associated with poor outcomes in CKD. Because impaired renal ammonium excretion is important in the pathogenesis of acidosis, urine ammonium excretion might be a better and perhaps earlier acid\u2013base indicator of risk than serum bicarbonate, particularly in patients without acidosis. We evaluated the association between baseline ammonium excretion and clinical outcomes in African American Study of Kidney Disease and Hypertension participants (\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    =1044). Median daily ammonium excretion was 19.5 (95% confidence interval [95% CI], 6.5 to 43.2) mEq. In Cox regression models (adjusted for demographics, measured GFR, proteinuria, body mass index, net endogenous acid production, and serum potassium and bicarbonate), hazard ratios of the composite outcome of death or dialysis were 1.46 (95% CI, 1.13 to 1.87) in the low tertile and 1.14 (95% CI, 0.89 to 1.46) in the middle tertile of daily ammonium excretion compared with the high tertile. Among participants without acidosis at baseline, the adjusted hazard ratio for those with ammonium excretion &lt;20 mEq\/d was 1.36 (95% CI, 1.09 to 1.71) compared with those with ammonium excretion \u226520 mEq\/d. Additionally, compared with participants in the high ammonium tertile, those in the low ammonium tertile had higher adjusted odds of incident acidosis at 1 year (adjusted odds ratio, 2.56; 95% CI, 1.04 to 6.27). In conclusion, low ammonium excretion is associated with death and renal failure in hypertensive kidney disease, even among those without acidosis. Low ammonium excretion could identify patients with CKD and normal bicarbonate levels who might benefit from alkali before acidosis develops.\n                  <\/jats:p>","DOI":"10.1681\/asn.2016101151","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T22:11:25Z","timestamp":1491516685000},"page":"2483-2490","source":"Crossref","is-referenced-by-count":93,"title":["Urine Ammonium Predicts Clinical Outcomes in Hypertensive Kidney Disease"],"prefix":"10.1681","volume":"28","author":[{"given":"Kalani L.","family":"Raphael","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Utah, Salt Lake City, Utah and"},{"name":"VA Salt Lake City Health Care System, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Utah, Salt Lake City, Utah and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Utah, Salt Lake City, Utah and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Greene","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Utah, Salt Lake City, Utah and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Beddhu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Utah, Salt Lake City, Utah and"},{"name":"VA Salt Lake City Health Care System, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"key":"B1-20230819","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","article-title":"Timing of onset of CKD-related metabolic complications.","volume":"20","author":"Moranne","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B2-20230819","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/nep.12315","article-title":"Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease.","volume":"19","author":"Raphael","year":"2014","journal-title":"Nephrology (Carlton)"},{"key":"B3-20230819","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ndt\/gfn633","article-title":"Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD.","volume":"24","author":"Kovesdy","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B4-20230819","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.ajkd.2010.03.023","article-title":"Serum bicarbonate and long-term outcomes in CKD.","volume":"56","author":"Menon","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B5-20230819","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ki.2010.388","article-title":"Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans.","volume":"79","author":"Raphael","year":"2011","journal-title":"Kidney Int"},{"key":"B6-20230819","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/ndt\/gfs609","article-title":"Serum bicarbonate and mortality in adults in NHANES III.","volume":"28","author":"Raphael","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B7-20230819","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.ajkd.2009.02.014","article-title":"Serum bicarbonate levels and the progression of kidney disease: A cohort study.","volume":"54","author":"Shah","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"B8-20230819","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ki.2015.52","article-title":"Urinary ammonia and long-term outcomes in chronic kidney disease.","volume":"88","author":"Vallet","year":"2015","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"B9-20230819","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"B10-20230819","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","article-title":"Bicarbonate supplementation slows progression of CKD and improves nutritional status.","volume":"20","author":"de Brito-Ashurst","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B11-20230819","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ki.2009.519","article-title":"Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR.","volume":"77","author":"Phisitkul","year":"2010","journal-title":"Kidney Int"},{"key":"B12-20230819","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2369-14-4","article-title":"High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients.","volume":"14","author":"Kanda","year":"2013","journal-title":"BMC Nephrol"},{"key":"B13-20230819","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ki.2010.129","article-title":"Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy.","volume":"78","author":"Mahajan","year":"2010","journal-title":"Kidney Int"},{"key":"B14-20230819","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI112020","article-title":"Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3.","volume":"76","author":"Nath","year":"1985","journal-title":"J Clin Invest"},{"key":"B15-20230819","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1172\/JCI112973","article-title":"Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury.","volume":"79","author":"Tolins","year":"1987","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"B16-20230819","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1097\/01.ASN.0000070081.15137.C0","article-title":"The rationale and design of the AASK cohort study.","volume":"14","author":"Appel","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B17-20230819","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/archinte.168.8.832","article-title":"Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.","volume":"168","author":"Appel","year":"2008","journal-title":"Arch Intern Med"},{"key":"B18-20230819","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial.","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"B19-20230819","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ki.1985.10","article-title":"A method for estimating nitrogen intake of patients with chronic renal failure.","volume":"27","author":"Maroni","year":"1985","journal-title":"Kidney Int"},{"key":"B20-20230819","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ajcn\/68.3.576","article-title":"Estimation of net endogenous noncarbonic acid production in humans from diet potassium and protein contents.","volume":"68","author":"Frassetto","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"B21-20230819","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ije\/dyr218","article-title":"Recommendations for presenting analyses of effect modification and interaction.","volume":"41","author":"Knol","year":"2012","journal-title":"Int J Epidemiol"},{"key":"B22-20230819","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.annepidem.2006.10.009","article-title":"Test for additive interaction in proportional hazards models.","volume":"17","author":"Li","year":"2007","journal-title":"Ann Epidemiol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201708000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:28:56Z","timestamp":1786130936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201708000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2016101151","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,6]]}}}